Replies to post #16507 on Oncolix Inc. (fka ONCX)

[laraz5]

It's far worse then we even thought

For the year ended December 31, 2016, we reported a net loss of $1.4 million; and as of December 31, 2016, we had an accumulated deficit of $19.0 million. For the nine months ended September 30, 2017, we reported a net loss of $2.1 million; and as of September 30, 2017, we had an accumulated deficit of $21.1 million. We expect to continue to incur significant losses for the foreseeable future, and we expect these losses to increase as we continue our research and development of, and seek regulatory approvals for, Prolanta™

https://ih.advfn.com/p.php?pid=nmona&article=76674437


IMO